Hobart Rogers
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 4
- Nephrology top 10%
-
- Pharmaceutical studies and practices 3
-
- DNA and Nucleic Acid Chemistry 2
- RNA Interference and Gene Delivery 2
- Advanced biosensing and bioanalysis techniques 2
-
- Health Systems, Economic Evaluations, Quality of Life 2
-
- Pesticide Residue Analysis and Safety 1
-
- Bacteriophages and microbial interactions 1
- Co-authors
- Michael PacanowskiBadrul A. ChowdhuryRobert LimCurtis J. RosebraughAnthony G. DurmowiczIssam ZinehVikram AryaErika Feller
- Journals
- Pharmacogenomics (2 papers)Nucleic Acid Therapeutics (2 papers)Annals of the American Thoracic Society (1 paper)
- Partner nations
- United StatesSwedenSwitzerland
In The Last Decade
Hobart Rogers
12 papers receiving 342 citations
Peers
Comparison fields: 5 of 71
- Pharmacology 55
- Nephrology 44
- Pulmonary and Respiratory Medicine 136
- Cardiology and Cardiovascular Medicine 74
- Biological Psychiatry 7
Countries citing papers authored by Hobart Rogers
This map shows the geographic impact of Hobart Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hobart Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hobart Rogers more than expected).
Fields of papers citing papers by Hobart Rogers
This network shows the impact of papers produced by Hobart Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hobart Rogers. The network helps show where Hobart Rogers may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hobart Rogers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2022 | 8 | |
| 3 | 2022 | 36 | |
| 4 | 2020 | 19 | |
| 5 | 2018 | 12 | |
| 6 | 2017 | 101 | |
| 7 | 2016 | 10 | |
| 8 | 2016 | 6 | |
| 9 | 2013 | 27 | |
| 10 | 2012 | 26 | |
| 11 | 2011 | 28 | |
| 12 | 2008 | 76 |
About Hobart Rogers
Hobart Rogers is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Nephrology, having authored 12 papers that have together received 351 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Pharmaceutical studies and practices (3 papers), DNA and Nucleic Acid Chemistry (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), RNA Interference and Gene Delivery (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Pesticide Residue Analysis and Safety (1 paper) and Bacteriophages and microbial interactions (1 paper). The work is most often cited by research in Pharmacology (55 citations), Nephrology (44 citations) and Pulmonary and Respiratory Medicine (136 citations). Hobart Rogers has collaborated with scholars based in United States, Sweden and Switzerland. Frequent co-authors include Michael Pacanowski, Badrul A. Chowdhury, Robert Lim, Curtis J. Rosebraugh, Anthony G. Durmowicz, Issam Zineh, Vikram Arya, Erika Feller, Thomas C. Dowling and Jeremy S. Bock. Their work appears in journals such as Pharmacogenomics, Nucleic Acid Therapeutics, Annals of the American Thoracic Society, The Journal of Clinical Psychiatry and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.